Werewolf Therapeutics, Inc. (HOWL)
HOWL Stock Price Chart
Explore Werewolf Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze HOWL price movements and trends.
HOWL Company Profile
Discover essential business fundamentals and corporate details for Werewolf Therapeutics, Inc. (HOWL) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
30 Apr 2021
Employees
46.00
Website
https://werewolftx.comCEO
Daniel J. Hicklin
Description
Werewolf Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing novel therapies that activate the body's immune system to combat cancer. Leveraging its exclusive PREDATOR platform, the company crafts conditionally activated molecules designed to stimulate both adaptive and innate immunity. This strategic approach aims to circumvent the shortcomings often associated with traditional proinflammatory immune treatments. Key among its product pipeline are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule targeting advanced solid tumors, and WTX-330, an Interleukin-12 INDUKINE molecule also designed for conditional activation, intended for advanced or metastatic solid tumors or lymphomas that have relapsed or are refractory. Furthermore, Werewolf Therapeutics is progressing WTX-613, a conditionally activated interferon alpha INDUKINE molecule, for addressing solid tumors and hematologic malignancies. The company was founded in 2017 and operates from its headquarters in Cambridge, Massachusetts.
HOWL Financial Timeline
Browse a chronological timeline of Werewolf Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 Aug 2026
EPS estimate is -$0.28.
Earnings released on 7 May 2026
EPS came in at -$0.28 surpassing the estimated -$0.32 by +12.50%.
Earnings released on 27 Mar 2026
EPS came in at -$0.20 surpassing the estimated -$0.34 by +41.18%.
Earnings released on 4 Nov 2025
EPS came in at -$0.36 surpassing the estimated -$0.39 by +7.69%.
Earnings released on 14 Aug 2025
EPS came in at -$0.40 surpassing the estimated -$0.50 by +20.00%.
Earnings released on 8 May 2025
EPS came in at -$0.40 surpassing the estimated -$0.44 by +9.09%.
Earnings released on 11 Mar 2025
EPS came in at -$0.46 falling short of the estimated -$0.43 by -6.98%.
Earnings released on 7 Nov 2024
EPS came in at -$0.38 surpassing the estimated -$0.41 by +7.32%.
Earnings released on 8 Aug 2024
EPS came in at -$0.40 falling short of the estimated -$0.38 by -5.26%, while revenue for the quarter reached $1.14m , beating expectations by +35.78%.
Earnings released on 3 May 2024
EPS came in at -$0.39 falling short of the estimated -$0.35 by -11.43%, while revenue for the quarter reached $742.00k , missing expectations by -49.09%.
Earnings released on 7 Mar 2024
EPS came in at -$0.33 surpassing the estimated -$0.43 by +23.26%, while revenue for the quarter reached $1.50m , missing expectations by -22.78%.
Earnings released on 14 Nov 2023
EPS came in at -$0.23 surpassing the estimated -$0.39 by +41.03%, while revenue for the quarter reached $5.90m , beating expectations by +270.65%.
Earnings released on 10 Aug 2023
EPS came in at -$0.14 surpassing the estimated -$0.42 by +66.67%, while revenue for the quarter reached $8.08m , beating expectations by +156.54%.
Earnings released on 11 May 2023
EPS came in at -$0.34 surpassing the estimated -$0.50 by +32.00%, while revenue for the quarter reached $4.46m , beating expectations by +119.54%.
Earnings released on 23 Mar 2023
EPS came in at -$0.39 surpassing the estimated -$0.55 by +29.09%, while revenue for the quarter reached $7.28m , beating expectations by +251.50%.
Earnings released on 10 Nov 2022
EPS came in at -$0.40 surpassing the estimated -$0.60 by +33.33%, while revenue for the quarter reached $4.97m , beating expectations by +62.95%.
Earnings released on 11 Aug 2022
EPS came in at -$0.53 falling short of the estimated -$0.43 by -23.26%, while revenue for the quarter reached $4.15m , missing expectations by -17.04%.
Earnings released on 10 May 2022
EPS came in at -$0.56 surpassing the estimated -$0.61 by +8.20%.
Earnings released on 24 Mar 2022
EPS came in at -$0.66 falling short of the estimated -$0.53 by -24.53%.
Earnings released on 10 Nov 2021
EPS came in at -$0.51 falling short of the estimated -$0.44 by -15.91%.
Earnings released on 12 Aug 2021
EPS came in at -$3.82 falling short of the estimated -$0.37 by -932.43%.
HOWL Stock Performance
Access detailed HOWL performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
